Fentanyl Market Report 2026
Global Outlook – By Type (Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)), By Application (Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Fentanyl Market Overview
• Fentanyl market size has reached to $17.15 billion in 2025 • Expected to grow to $23.8 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Incidence Of Chronic Diseases Drives Growth In The Fentanyl Market • Market Trend: Increasing Focus On Product Approvals To Gain The Revenues • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Fentanyl Market?
Fentanyl refers to a synthetic opioid that is highly potent and used for pain relief and anesthesia purposes. It is used by doctors to alleviate extreme pain, particularly after surgery and in advanced-stage cancer. It is offered as transdermal patches or lozenges. The main types of fentanyl are fentanyl injections, fentanyl TTS (transdermal therapeutic system). Fentanyl injections are a form of medication that delivers the opioid fentanyl directly into the bloodstream. They are primarily used to relieve severe pain during and after surgery. It is used for various applications such as anesthesia, maintain anesthesia, general analgesic, postoperative analgesia, and breakthrough cancer pain by hospitals, clinics, ambulatory surgical centers, and others.
What Is The Fentanyl Market Size and Share 2026?
The fentanyl market size has grown strongly in recent years. It will grow from $17.15 billion in 2025 to $18.17 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rising prevalence of chronic and cancer pain, increased postoperative surgeries, growing geriatric population, high adoption of injectable opioids, expansion of hospital and clinical infrastructure.What Is The Fentanyl Market Growth Forecast?
The fentanyl market size is expected to see strong growth in the next few years. It will grow to $23.8 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to development of novel fentanyl formulations, integration of AI in pain management, rising demand for home-based palliative care, increasing focus on opioid safety and regulation, growth of ambulatory surgical centers. Major trends in the forecast period include personalized pain management, novel transdermal drug delivery systems, minimally invasive anesthesia techniques, opioid stewardship programs, advanced formulation development.
Global Fentanyl Market Segmentation
1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System) 2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain 3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations 2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch SystemsWhat Is The Driver Of The Fentanyl Market?
The increasing prevalence of chronic diseases is expected to propel the growth of the fentanyl market going forward. A chronic disease is a medical condition that persists over a long period, typically for three months or more, and often continues throughout a person's life. Fentanyl is used in chronic diseases primarily to manage severe, persistent pain that other medications or interventions do not effectively control. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency reported that in 2023, an estimated 57,100 adults aged 25 and above experienced acute coronary events, averaging roughly 156 incidents per day. Therefore, the increasing prevalence of chronic diseases is driving the growth of the fentanyl industry.Key Players In The Global Fentanyl Market
Major companies operating in the fentanyl market are Pfizer Inc., Johnson & Johnson, Fresenius Kabi Oncology Ltd., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Hisamitsu Pharmaceutical Co. Inc., Alvogen, Insys Therapeutics Inc., Paladin Labs Inc., Apotex Inc., Kyowa Kirin Co. Ltd., Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Sinopharm Group, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, Validus Pharmaceuticals LLC, Quality Care Products LLC, Bryant Ranch Prepack Inc., Exela Pharma Sciences LLC
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Fentanyl Market Trends and Insights
Major companies operating in the fentanyl market are developing innovative products such as Opvee and getting approvals to meet larger customer bases, more sales, and increased revenue. Opvee (nalmefene) is a potent opioid receptor blocker used to treat known or suspected opioid overdose induced by natural or synthetic opioids like fentanyl. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, received U.S. Food and Drug Administration approval for Opvee nasal spray. It functions by preventing the effects of opioids on the brain, which can help patients who have recently overdosed get their respiration and blood pressure back to normal. Opvee is delivered as a nasal spray, making it easy to administer in emergencies. It is essential to the range of medications used to combat opioid overdoses and save lives.What Are Latest Mergers And Acquisitions In The Fentanyl Market?
In April 2023, SK Capital Partners LP, a US-based private investment company, acquired Apotex Pharmaceutical Holdings Inc. for an undisclosed amount. This acquisition aims to broaden Apotex's product line, establish it as a Canadian global health firm, and capitalize on its expertise in low-cost drugs. Apotex Pharmaceutical Holdings Inc. is a Canada-based pharmaceutical company producing fentanyl transdermal systems.
Regional Insights
North America was the largest region in the fentanyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Fentanyl Market?
The fentanyl market consists of sales of fentanyl patch, fentanyl lozenge, fentanyl nasal spray, fentanyl sublingual spray, fentanyl sublingual tablets, fentanyl lollipop, and fentanyl film. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Fentanyl Market Report 2026?
The fentanyl market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fentanyl industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Fentanyl Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $18.17 billion |
| Revenue Forecast In 2030 | $23.8 billion |
| Growth Rate | CAGR of 5.9% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Pfizer Inc., Johnson & Johnson, Fresenius Kabi Oncology Ltd., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Hisamitsu Pharmaceutical Co. Inc., Alvogen, Insys Therapeutics Inc., Paladin Labs Inc., Apotex Inc., Kyowa Kirin Co. Ltd., Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Sinopharm Group, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, Validus Pharmaceuticals LLC, Quality Care Products LLC, Bryant Ranch Prepack Inc., Exela Pharma Sciences LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |